There's No Escaping Sinopharm Group Co. Ltd.'s (HKG:1099) Muted Earnings Despite A 32% Share Price Rise

Simply Wall St18:29 ET

While Shareholders of Sinopharm Group (HKG:1099) Are in the Red Over the Last Five Years, Underlying Earnings Have Actually Grown

Simply Wall StSep 26 20:32 ET

The concept of innovative drugs is generally rising. Akeso (09926) rose by 3.78%. Institutions point out that the investment and financing environment in the pharmaceutical industry is expected to recover rapidly.

Jingu Finance News | The concept of innovative drugs is generally rising, with Akeso (09926) up 3.78%, Zai Lab (09688) up 3.38%, Asymchem Laboratories (06855) up 3.11%, Innovent Bio (01801) up 3.02%, Sinopharm (01099) up 2.78%, Junshi Bio (01877) up 2.15%, Wuxi Bio (02269) up 1.71%, Beigene (06160) up 0.8%. CSC Securities released a research report stating that with the Federal Reserve announcing its first rate cut since March 2020, global liquidity

Golden Finance NewsSep 24 21:36 ET

Sinopharm Group's H1 Profit Declines 10% as Revenue Drops

MT NewswiresSep 24 20:00 ET

Express News | Sinopharm Group H1 Basic EPS RMB 1.19

ReutersSep 24 18:08 ET

SINOPHARM: Interim Report 2024

HKEXSep 24 18:07 ET · Announcements